<--- Back to Details
First PageDocument Content
Clinical research / Research / Department of Health / Medicines and Healthcare products Regulatory Agency / Pharmaceuticals policy / Trading fund / Yellow Card Scheme / Health Protection Agency / Postmarketing surveillance / Medicine / Pharmaceutical industry / Health
Date: 2014-06-05 08:12:21
Clinical research
Research
Department of Health
Medicines and Healthcare products Regulatory Agency
Pharmaceuticals policy
Trading fund
Yellow Card Scheme
Health Protection Agency
Postmarketing surveillance
Medicine
Pharmaceutical industry
Health

Issue number 01 Effective date

Add to Reading List

Source URL: www.mhra.gov.uk

Download Document from Source Website

File Size: 221,49 KB

Share Document on Facebook

Similar Documents

Pharmaceuticals policy / Health / Medical research / Pharmacovigilance / European Medicines Agency / EudraLex / European Directive on Traditional Herbal Medicinal Products / Postmarketing surveillance / Adverse effect / Qualified Person Responsible For Pharmacovigilance / EudraVigilance

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

DocID: 1qH6O - View Document

Medicine / Clinical research / Pharmaceuticals policy / Medical technology / Medical equipment / Postmarketing surveillance / Research / Medical device / Administrative guidance

IMDRF Presentation - WHO update

DocID: 1q40h - View Document

Medical equipment / Clinical research / Medical technology / Pharmaceuticals policy / Clinical trials / Postmarketing surveillance / Medical device / Global Harmonization Task Force / Interactive television / Validation

IMDRF Presentation - Update on WHO work

DocID: 1oBkV - View Document

Health / Medicine / Pharmaceuticals policy / Drug safety / Pharmacy / Pharmacovigilance / EudraLex / Qualified Person Responsible For Pharmacovigilance / Postmarketing surveillance / Pharmacology / Pharmaceutical sciences / Clinical research

Microsoft Word - Volume IX ENdoc

DocID: 1g2y9 - View Document

Pharmaceutical industry / Health / Pharmaceuticals policy / Clinical research / Pharmacovigilance / Good manufacturing practice / Postmarketing surveillance / Pharmaceutical sciences / Pharmacy / Pharmacology

Kyrgyzstan Assessment of Pharmaceutical Data Disclosure Disclosure Status of Pharmaceutical Sector Data Part of Component 1 of the MeTA Baseline Assessments Kyrgyz Republic

DocID: 1fUrF - View Document